Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford launched its first Public Engagement with Research Strategic Plan to an audience of over 100 staff at a reception at the Pitt Rivers Museum on 12th December 2016.

Cover of the Public Engagement with Research Strategic PlanOxford’s vision is to embed high-quality and innovative public engagement as an integral part of its research culture and practice, enhancing its position as a world-leading research institution.

The consultation process for the development of the Plan gathered views and input from across the University, involving academic and academic support staff at all levels and the Plan has been approved by the University’s Research Committee.

The purpose of the University’s Public Engagement with Research Strategic Plan is two-fold:

  • to frame an ambitious vision for Public Engagement with Research at Oxford;
  • to  identify the key steps towards it that will be undertaken in the next three years and against which to measure progress.

Find out more from the Public Engagement with Research Portal

Download the Strategic plan

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.